Literature DB >> 6377597

Cyclosporine: experience with therapeutic monitoring.

L D Bowers, D M Canafax.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6377597

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  7 in total

1.  Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.

Authors:  Kelong Han; Robert Bies; Heather Johnson; Blair Capitano; Raman Venkataramanan
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

2.  Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.

Authors:  S K Gupta; B Legg; L R Solomon; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

Review 3.  Population pharmacokinetics of cyclosporine in transplant recipients.

Authors:  Kelong Han; Venkateswaran C Pillai; Raman Venkataramanan
Journal:  AAPS J       Date:  2013-06-18       Impact factor: 4.009

4.  Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model.

Authors:  C H Mody; G B Toews; M F Lipscomb
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 5.  Clinical pharmacokinetics in infants and children. A reappraisal.

Authors:  G L Kearns; M D Reed
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

6.  Ciclosporin concentration in the rabbit aqueous humor and cornea following subconjunctival administration. Importance of anatomical site of injection.

Authors:  W Behrens-Baumann; S Theuring; B Frey; F Frey; H Sostmann; J Bircher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

7.  Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.

Authors:  Kelong Han; B Capitano; R Bies; B A Potoski; S Husain; S Gilbert; D L Paterson; K McCurry; R Venkataramanan
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.